The approval further adds to Biocon's portfolio of complex drug products and will be commercialised in the region ...

Biocon said that it's wholly owned subsidiary, Biocon Pharma, has received approval for Tacrolimus capsule in 0.5mg, 1mg and 5mg strengths, from the National Medical Products Administration (NMPA), ...

Itolizumab is under clinical development by Biocon and currently in Phase I for Coronavirus Disease 2019 (COVID-19) Pneumonia.

Bangalore: Biocon has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received approval ...

Avenue Supermarts Ltd, which owns and operates retail chain DMart, has reported a 17.5 per cent increase in standalone ...

Stocks including Bharti Airtel, IRFC, Varun Beverages, RITES, Biocon, NHPC, PB Fintech, Swan Energy, Wockhardt and more will ...

The proposed Biosecure Act as well as the diversification of American and European firms away from China are expected to help ...

The rise in Biocon share price came after it announced that the company and its European partner, Zentiva, have received a ...

India to become a global leader in development of complex biotherapeutic products: Kiran Mazumdar Shaw: Nandita Vijayasimha, Bengaluru Tuesday, December 31, 2024, 08:00 Hrs [IST] ...

As markets open today, several companies such as Zee, DMart, IRFC, ITC, Bharti Airtel, Hero MotoCorp are expected to grab ...

Capital Small Finance Bank, V2 Retail and V-Mart Retail are some of the other stocks that will be on the radar on Friday.

"This is to inform you that Biocon Pharma Limited, a wholly owned subsidiary of the company, has received approval for ...